CA2682994A1 - Composes heterocycliques presentant une affinite pour les recepteurs muscariniques - Google Patents
Composes heterocycliques presentant une affinite pour les recepteurs muscariniques Download PDFInfo
- Publication number
- CA2682994A1 CA2682994A1 CA002682994A CA2682994A CA2682994A1 CA 2682994 A1 CA2682994 A1 CA 2682994A1 CA 002682994 A CA002682994 A CA 002682994A CA 2682994 A CA2682994 A CA 2682994A CA 2682994 A1 CA2682994 A1 CA 2682994A1
- Authority
- CA
- Canada
- Prior art keywords
- pyrazol
- compound
- tetrahydro
- methylpyridine
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91358407P | 2007-04-24 | 2007-04-24 | |
| EP07106814.2 | 2007-04-24 | ||
| EP07106814 | 2007-04-24 | ||
| US60/913,584 | 2007-04-24 | ||
| PCT/EP2008/054897 WO2008129054A2 (fr) | 2007-04-24 | 2008-04-23 | Composés hétérocycliques présentant une affinité pour les récepteurs muscariniques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2682994A1 true CA2682994A1 (fr) | 2008-10-30 |
Family
ID=38510408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002682994A Abandoned CA2682994A1 (fr) | 2007-04-24 | 2008-04-23 | Composes heterocycliques presentant une affinite pour les recepteurs muscariniques |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2150543A2 (fr) |
| JP (1) | JP2010525020A (fr) |
| CN (1) | CN101939311A (fr) |
| AU (1) | AU2008240704A1 (fr) |
| CA (1) | CA2682994A1 (fr) |
| MX (1) | MX2009011499A (fr) |
| RU (1) | RU2446166C2 (fr) |
| WO (1) | WO2008129054A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8084473B2 (en) | 2007-04-24 | 2011-12-27 | Solvay Pharmaceuticals B.V. | Heterocyclic compounds with affinity to muscarinic receptors |
| CN102459175A (zh) * | 2009-05-07 | 2012-05-16 | 托蓝特医药公司 | 用于治疗糖尿病的哌啶衍生物 |
| JP5996532B2 (ja) | 2010-07-15 | 2016-09-21 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 有害生物防除剤としての新規複素環式化合物 |
| CA2880326A1 (fr) * | 2012-10-26 | 2014-05-01 | F. Hoffmann-La Roche Ag | Inhibiteurs 3,4-disubstitue 1h-pyrazole et 4,5-disubstitue thiazole de syk |
| AR121893A1 (es) | 2020-04-22 | 2022-07-20 | Sumitomo Chemical Co | Compuesto de fenilo y método para controlar enfermedades vegetales |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL83275A (en) * | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
| WO1999062885A1 (fr) * | 1998-06-05 | 1999-12-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1-(4-aminophenyl) pyrazoles substitues et leur utilisation en tant qu'agents anti-inflammatoires |
| CN1571787A (zh) * | 2001-10-17 | 2005-01-26 | Ucb公司 | 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途 |
| US6861440B2 (en) * | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
| WO2006070198A1 (fr) * | 2004-12-30 | 2006-07-06 | Astex Therapeutics Limited | Derives pyrazoliques modulant l'activite des kinases cdk, gsk et aurora |
-
2008
- 2008-04-23 AU AU2008240704A patent/AU2008240704A1/en not_active Abandoned
- 2008-04-23 RU RU2009143353/04A patent/RU2446166C2/ru not_active IP Right Cessation
- 2008-04-23 CA CA002682994A patent/CA2682994A1/fr not_active Abandoned
- 2008-04-23 EP EP08759382A patent/EP2150543A2/fr not_active Withdrawn
- 2008-04-23 JP JP2010504671A patent/JP2010525020A/ja not_active Withdrawn
- 2008-04-23 MX MX2009011499A patent/MX2009011499A/es not_active Application Discontinuation
- 2008-04-23 CN CN2008800165261A patent/CN101939311A/zh active Pending
- 2008-04-23 WO PCT/EP2008/054897 patent/WO2008129054A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008240704A1 (en) | 2008-10-30 |
| WO2008129054A2 (fr) | 2008-10-30 |
| WO2008129054A3 (fr) | 2009-02-05 |
| RU2446166C2 (ru) | 2012-03-27 |
| EP2150543A2 (fr) | 2010-02-10 |
| JP2010525020A (ja) | 2010-07-22 |
| RU2009143353A (ru) | 2011-05-27 |
| CN101939311A (zh) | 2011-01-05 |
| MX2009011499A (es) | 2009-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3083618B1 (fr) | Nouvelles 1h-pyrrolo[2,3- b]pyridines 3,4-disubstituées et 7h-pyrrolo[2,3-c]pyridazines 4,5-disubstituées en tant qu'inhibiteurs de la lrrk2 | |
| JP5433418B2 (ja) | 多環式化合物 | |
| CA2627839C (fr) | Derives pyrrolo-[2,1-f]-[1,2,4]-triazin-4-ylamines inhibiteurs de la igf-1r kinase pour le traitement des cancers et autres maladies hyperproliferatives | |
| AU2007292155B2 (en) | Imidazole derivative | |
| JP2022516785A (ja) | 置換ピロリジンアミドｉｉｉ | |
| JPH11513679A (ja) | 薬剤活性キナゾリン化合物 | |
| JP6305510B2 (ja) | ヤヌスキナーゼ阻害剤としての非環式シアノエチルピラゾロピリドン | |
| BG62521B1 (bg) | Производни на нафтален, метод и междинни съединения затяхното получаване | |
| EP2155716A2 (fr) | Dérivés hétérocycliques substitués et leur utilisation pharmaceutique et compositions | |
| WO2011138657A1 (fr) | Composés oléfiniques à substitution aryle en tant qu'inhibiteurs de la pde10a | |
| EP3704112B1 (fr) | Composés alkène-spirocycliques en tant que modulateurs du récepteur de farnésoïde x | |
| AU2008235456A1 (en) | [2, 6] naphthyridines useful as protein kinase inhibitors | |
| KR20010094731A (ko) | 이미다졸 화합물 및 그의 의약 용도 | |
| WO2022060996A1 (fr) | Inhibiteurs de raf kinases | |
| WO2022152852A1 (fr) | Antagonistes de mrgx2 | |
| AU2008256859A1 (en) | 4' substituted compounds having 5-HT6 receptor affinity | |
| CA2682994A1 (fr) | Composes heterocycliques presentant une affinite pour les recepteurs muscariniques | |
| TW202140499A (zh) | 巨環ｒｉｐ２－激酶抑制劑 | |
| JP2564714B2 (ja) | １−（置換ピリジニルアミノ）−１ｈ−インドール−５−イル置換カルバメート | |
| AU2006298164A1 (en) | Novel fused pyrrole derivative | |
| US8735388B2 (en) | Heterocyclic compounds with affinity to muscarinic receptors | |
| KR20260005244A (ko) | 치환된 티오펜 융합 유도체, 이를 포함하는 조성물, 및 의약품으로서의 이들의 용도 | |
| WO2018109271A1 (fr) | Nouveaux inhibiteurs de bromodomaines | |
| HK1147480A (en) | Heterocyclic compounds with affinity to muscarinic receptors | |
| WO2015173393A1 (fr) | Composés d'oxindole portant un substituant spiro lié à un atome d'azote, et leur utilisation pour le traitement de maladies liées à la vasopressine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20140423 |